Mette Hurlen

1.5k total citations · 1 hit paper
18 papers, 1.1k citations indexed

About

Mette Hurlen is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mette Hurlen has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 4 papers in Internal Medicine and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mette Hurlen's work include Atrial Fibrillation Management and Outcomes (13 papers), Acute Myocardial Infarction Research (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Mette Hurlen is often cited by papers focused on Atrial Fibrillation Management and Outcomes (13 papers), Acute Myocardial Infarction Research (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (8 papers). Mette Hurlen collaborates with scholars based in Norway and United States. Mette Hurlen's co-authors include Harald Arnesen, Michael Abdelnoor, Jan Erikssen, Pål Smith, Ingebjørg Seljeflot, Peter G. Smith, Jan Erikssen, Lars Eikvar, Svein Solheim and Torstein Hole and has published in prestigious journals such as New England Journal of Medicine, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Mette Hurlen

18 papers receiving 1.0k citations

Hit Papers

Warfarin, Aspirin, or Both after Myocardial Infarction 2002 2026 2010 2018 2002 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Warfarin, Aspirin, or Both after Myocardial Infarction
    2002 561 citations Mette Hurlen, Michael Abdelnoor et al. New England Journal of Medicine profile →

Peers

Mette Hurlen
Sasidhar Guthikonda United States
William Ng China
Chantal Pharand Canada
Basil A. Molony United States
Paul A. Gurbel United States
Anne Bellemain-Appaix France
Patricia A. Gum United States
Dániel Aradi Hungary
E Panak France
Libardo J. Meléndez Canada
Sasidhar Guthikonda United States
Mette Hurlen
Citations per year, relative to Mette Hurlen Mette Hurlen (= 1×) peers Sasidhar Guthikonda

Countries citing papers authored by Mette Hurlen

Since Specialization
Citations

This map shows the geographic impact of Mette Hurlen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mette Hurlen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mette Hurlen more than expected).

Fields of papers citing papers by Mette Hurlen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mette Hurlen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mette Hurlen. The network helps show where Mette Hurlen may publish in the future.

Co-authorship network of co-authors of Mette Hurlen

This figure shows the co-authorship network connecting the top 25 collaborators of Mette Hurlen. A scholar is included among the top collaborators of Mette Hurlen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mette Hurlen. Mette Hurlen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Hurlen, Mette, et al.. (2008). Less Benefit from Warfarin in Diabetics after Myocardial Infarction?. Cardiology. 111(3). 161–166. 4 indexed citations
2.
Brodin, Ellen, et al.. (2008). Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment. Thrombosis Research. 123(4). 573–579. 21 indexed citations
3.
Hurlen, Mette & Harald Arnesen. (2008). Oral Anticoagulation after Myocardial Infarction. Herz. 33(1). 38–43. 1 indexed citations
4.
Hurlen, Mette, Lars Eikvar, Ingebjørg Seljeflot, & Harald Arnesen. (2005). Occult bleeding in three different antithrombotic regimes after myocardial infarction. Thrombosis Research. 118(4). 433–438. 15 indexed citations
5.
Seljeflot, Ingebjørg, Mette Hurlen, & Harald Arnesen. (2004). Increased levels of soluble tissue factor during long‐term treatment with warfarin in patients after an acute myocardial infarction. Journal of Thrombosis and Haemostasis. 2(5). 726–730. 10 indexed citations
6.
Solheim, Svein, Harald Arnesen, Lars Eikvar, Mette Hurlen, & Ingebjørg Seljeflot. (2003). Influence of aspirin on inflammatory markers in patients after acute myocardial infarction. The American Journal of Cardiology. 92(7). 843–845. 46 indexed citations
7.
Seljeflot, Ingebjørg, Mette Hurlen, Torstein Hole, & Harald Arnesen. (2003). Soluble tissue factor as predictor of future events in patients with acute myocardial infarction. Thrombosis Research. 111(6). 369–372. 29 indexed citations
8.
Hurlen, Mette, et al.. (2003). Serum levels of the anti-inflammatory cytokine interleukin-10 are inversely associated with future events in patients with previous acute myocardial infarction. Journal of Thrombosis and Haemostasis. 1. P0496–P0496. 1 indexed citations
9.
Hurlen, Mette, Michael Abdelnoor, Peter G. Smith, Jan Erikssen, & Harald Arnesen. (2003). Warfarin, aspirin, or both after myocardial infarction. ACC Current Journal Review. 12(1). 11–12. 76 indexed citations
10.
Hurlen, Mette, et al.. (2002). Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thrombosis Research. 108(1). 37–42. 175 indexed citations
11.
Hurlen, Mette, Michael Abdelnoor, Pål Smith, Jan Erikssen, & Harald Arnesen. (2002). Warfarin, Aspirin, or Both after Myocardial Infarction. New England Journal of Medicine. 347(13). 969–974. 561 indexed citations breakdown →
12.
Hurlen, Mette, Torstein Hole, Ingebjørg Seljeflot, & Harald Arnesen. (2001). Aspirin Does Not Influence the Effect of Angiotensin-Converting Enzyme Inhibition on Left Ventricular Ejection Fraction 3 Months After Acute Myocardial Infarction. European Journal of Heart Failure. 3(2). 203–207. 7 indexed citations
13.
Hurlen, Mette, Ingebjørg Seljeflot, & Harald Arnesen. (2000). Increased Platelet Aggregability During Exercise in Patients With Previous Myocardial Infarction. Lack of Inhibition by Aspirin. Thrombosis Research. 99(5). 487–494. 50 indexed citations
14.
Hurlen, Mette, Ingebjørg Seljeflot, & Harald Arnesen. (1998). The Effect of Different Antithrombotic Regimens on Platelet Aggregation After Myocardial Infarction. Scandinavian Cardiovascular Journal. 32(4). 233–237. 28 indexed citations
15.
Hurlen, Mette, Jan Erikssen, Peter G. Smith, Harald Arnesen, & Arnfinn Rollag. (1994). Comparison of bleeding complications of warfarin and warfarin plus acetylsalicylic acid: a study in 3166 outpatients. Journal of Internal Medicine. 236(3). 299–304. 26 indexed citations
16.
Hurlen, Mette, et al.. (1989). Influence of age on physical performance, heart rate and systolic blood pressure response during exercise in apparently healthy women. Scandinavian Journal of Clinical and Laboratory Investigation. 49(1). 97–102. 2 indexed citations
17.
18.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sasidhar Guthikonda Breakdown of academic impact, for papers by William Ng Breakdown of academic impact, for papers by Chantal Pharand Breakdown of academic impact, for papers by Basil A. Molony Breakdown of academic impact, for papers by Paul A. Gurbel Breakdown of academic impact, for papers by Anne Bellemain-Appaix Breakdown of academic impact, for papers by Patricia A. Gum Breakdown of academic impact, for papers by Dániel Aradi Breakdown of academic impact, for papers by E Panak Breakdown of academic impact, for papers by Libardo J. Meléndez
Rankless by CCL
2026